Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No changes to core content or functionality.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded Aditya Sharma, MD as the study contact and removed Sajad Khazal, MD who was listed as Active, not recruiting.SummaryDifference0.2%

- Check33 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No other page content or functionality appears to be affected.SummaryDifference0.0%

- Check40 days agoChange DetectedVersion bump from v3.4.0 to v3.4.1. No study content or user-facing information was changed.SummaryDifference0.0%

- Check47 days agoChange DetectedUI and metadata text updates include adding a glossary toggle, updating the 'Last Update Submitted that Met QC Criteria' label capitalization, and displaying 'No FEAR Act Data' and 'Revision: v3.4.0' in the footer. No core study data, eligibility criteria, locations, or enrollment information were changed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study status was updated to Active, not recruiting on 2026-01-07. A new page revision (v3.3.4) was posted on 2026-01-07, replacing the previous v3.3.3 revision.SummaryDifference0.2%

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.